Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2004
09/15/2004EP1023319B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
09/15/2004EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY
09/15/2004EP1001806B1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
09/15/2004EP0942985B1 Broad-spectrum delta-endotoxins
09/15/2004EP0877760B1 Mhc complexes and uses thereof
09/15/2004EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor
09/15/2004CN1529758A Novel expression vectors and uses thereof
09/15/2004CN1529755A Novel bacterial phytases and method for producing same
09/15/2004CN1529753A Disease-associated protein
09/15/2004CN1529752A Alpha-amylase mutants with altered properties
09/15/2004CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer
09/15/2004CN1529710A Recombinant protective protein from streptococcus pneumoniae
09/15/2004CN1529607A Treatment of T cell disorders
09/15/2004CN1529551A Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use
09/15/2004CN1528904A Novel Plastid-targeting nucleic acid sequence, novel beta-amylase sequence and stimulus responsive promptor and uses thereof
09/15/2004CN1528791A Specific monoclonal antibody against epitope of clygoprotein coding inactivated feline immunodeficiency virus
09/15/2004CN1166777C Human Sel-10 polypeptides and polynucleotides that encode them
09/15/2004CN1166773C Differentiation of adipose stromal cells into osteobalsts
09/15/2004CN1166772C Process for controlling sialylation of protein produced by mammalian cell culture
09/15/2004CN1166283C Process for mass-producing virus-free seed bulbs of garlic through plant tissue culture technique
09/14/2004US6792356 Apparatus and method for automated protein design
09/14/2004US6791013 Nucleotide sequences coding regulatory sequences; for use in generating genetically engineered plant
09/14/2004US6791011 For producing male-sterile plants and hybrid seeds; cell ablation
09/14/2004US6791010 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications
09/14/2004US6791007 Polynucleotide and its use for modulating a defence response in plants
09/14/2004US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury
09/14/2004US6790950 Anti-bacterial vaccine compositions
09/14/2004US6790940 For high speed detection
09/14/2004US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins
09/14/2004US6790840 Reversibly cross-linked hydrogels
09/14/2004US6790826 Human haemopoietic maturation factor
09/14/2004US6790659 In vitro production of amoebocytes from tachypleus gigas in leibovitz culture medium
09/14/2004US6790658 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
09/14/2004US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments
09/14/2004US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders
09/14/2004US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques
09/14/2004US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes
09/14/2004US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions
09/14/2004US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment
09/14/2004US6790625 Antibodies to placental protein 13
09/14/2004US6790622 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
09/14/2004US6790619 Plant phosphomevalonate kinases
09/14/2004US6790612 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
09/14/2004US6790610 Alzheimer's disease, secretase, APP substrates therefor, and uses therefor
09/14/2004US6790606 Extracellular matrix signaling molecules
09/14/2004US6790455 Biodegradation membrane
09/14/2004US6790454 Processes for the preparation of novel collagen-based supports for tissue engineering, and biomaterials obtained
09/14/2004US6790449 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins
09/14/2004US6790446 Campylobacter vaccine
09/14/2004US6790441 Sertoli cells as biochambers
09/14/2004US6790440 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
09/14/2004CA2219629C Transgenic animal models for type ii diabetes mellitus
09/14/2004CA2161659C Retinal pigment epithelium transplantation
09/14/2004CA2073113C Conjugates
09/14/2004CA2071924C Hepatocellular carcinoma oncogene
09/10/2004WO2004076661A1 Establishment of disease nerve cells by combining method of highly efficiently inducing nerve differentiation with disease mutation knockin es cells
09/10/2004WO2004076653A1 Fetal cell isolation and enrichment
09/10/2004WO2004076652A1 Medium for stem cells to be used in intervertebral disk generation and regeneration of intervertebral disk using stem cells
09/10/2004WO2004076651A2 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines
09/10/2004WO2004076648A2 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response.
09/10/2004WO2004076631A2 Biologically active native biomatrix composition
09/10/2004WO2004076625A2 Method of identifying plant cells transformed with a gene
09/10/2004WO2004076624A2 Compositions and methods for neural cell production and stabilization
09/10/2004WO2004076620A2 Human antibodies specific for interleukin 15 (il-15)
09/10/2004WO2004076610A1 Apparatus and method for machining microchamber for cell culture
09/10/2004WO2004076608A2 Bioreactor and methods for tissue growth and conditioning
09/10/2004WO2004076488A1 A molecule which binds cd80 and cd86
09/10/2004WO2004076486A1 Method for reducing levels of c-reactive protein
09/10/2004WO2004075938A1 Implant body provided with a multiblock copolymer and polylysine coating
09/10/2004WO2004075937A1 Implant body having a multiblock copolymer coating
09/10/2004WO2004075861A2 Recombinant adeno-associated virus production
09/10/2004WO2004060869A3 Methods and compositions for catalytic dna exchange in a sequence manner
09/10/2004WO2004058175A3 Novel use of liver x receptor agonists
09/10/2004WO2004055155A3 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
09/10/2004WO2004053096A3 Engineering three-dimensional tissue structures using differentiating embryonic stem cells
09/10/2004WO2004045548A3 Genetic constructs and compositions comprising rre and cte and uses thereof
09/10/2004WO2004044147A3 Modified dendritic cells
09/10/2004WO2004042023A3 Stem cell libraries
09/10/2004WO2004039841A3 Trimeric binding proteins for trimeric cytokines
09/10/2004WO2004033622A3 Preservation of rna and morphology in cells and tissues
09/10/2004WO2004021772A3 Immune cloning and uses thereof
09/10/2004WO2004016731A3 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures
09/10/2004WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections
09/10/2004WO2003106970A3 P27 prevents cellular migration
09/10/2004WO2003045230A3 Novel compositions and methods for cancer
09/10/2004WO2002098890A3 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/10/2004WO2002094780A3 Kinases and phosphatases
09/10/2004CA2630024A1 Arabidopsis promoters
09/10/2004CA2517295A1 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines
09/10/2004CA2517108A1 Medium for stem cells in regeneration of intervertebral disc and regeneration of intervertebral disc using stem cells
09/10/2004CA2517082A1 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response
09/10/2004CA2517037A1 Method for reducing levels of c-reactive protein
09/10/2004CA2516832A1 A molecule which binds cd80 and cd86
09/10/2004CA2516378A1 Human antibodies specific for interleukin 15 (il-15)
09/10/2004CA2515588A1 Apparatus and method for machining microchamber for cell culture
09/10/2004CA2422906A1 Fish and seal collagens as cell matrices for cell culture
09/09/2004US20040177405 including drought and high salt concentration by increasing galactinol content; genetic engineering
09/09/2004US20040177397 Prenatal screening
09/09/2004US20040177396 Genetically engineered cleft palate rodent model comprising vector coding fluorescent reporter wherein gamma -aminobutyric acid neurons can be visualized in vivo; tissue engineering and diagnostic analysis
09/09/2004US20040177390 Method of nuclear transfer